<DOC>
	<DOCNO>NCT00725010</DOCNO>
	<brief_summary>The purpose program evaluate safety , tolerability , efficacy new concomitant sequential temozolomide regimen newly diagnose Glioblastoma patient routine care set .</brief_summary>
	<brief_title>Temozolomide Concomitant Radiochemotherapy Followed Sequential Temozolomide Chemotherapy - Observational Program ( Study P04816 )</brief_title>
	<detailed_description>Participant sample method : consecutive patient sampling .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Newly diagnose Glioblastoma multiforme History hypersensitivity temozolomide component , dacarbazine . Women pregnant breastfeeding . Patients severe myelosuppression .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>